Crystal structure of the µ-opioid receptor bound to a morphinan antagonist (original) (raw)

• Katzung, B. G. Basic and Clinical Pharmacology 10th edn (LANGE McGraw Hill Medical, 2007)
  Google Scholar
• Matthes, H. W. et al. Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the μ-opioid-receptor gene. Nature 383, 819–823 (1996)
  Article ADS CAS Google Scholar
• Lord, J. A., Waterfield, A. A., Hughes, J. & Kosterlitz, H. W. Endogenous opioid peptides: multiple agonists and receptors. Nature 267, 495–499 (1977)
  Article ADS CAS Google Scholar
• Raffa, R. B., Martinez, R. P. & Connelly, C. D. G-protein antisense oligodeoxyribonucleotides and μ-opioid supraspinal antinociception. Eur. J. Pharmacol. 258, R5–R7 (1994)
  Article CAS Google Scholar
• Shukla, A. K., Xiao, K. & Lefkowitz, R. J. Emerging paradigms of β-arrestin-dependent seven transmembrane receptor signaling. Trends Biochem. Sci. 36, 457–469 (2011)
  Article CAS Google Scholar
• Molinari, P. et al. Morphine-like opiates selectively antagonize receptor-arrestin interactions. J. Biol. Chem. 285, 12522–12535 (2010)
  Article CAS Google Scholar
• Rosenbaum, D. M. et al. GPCR engineering yields high-resolution structural insights into β2-adrenergic receptor function. Science 318, 1266–1273 (2007)
  Article ADS CAS Google Scholar
• Ballesteros, J. A. & Weinstein, H. Integrated Methods for the Construction of Three Dimensional Models and Computational Probing of Structure Function Relations in G Protein-Coupled Receptors Vol. 25 366–428 (Academic, 1995)
  CAS Google Scholar
• Chen, C. et al. Determination of the amino acid residue involved in [3H]β-funaltrexamine covalent binding in the cloned rat μ-opioid receptor. J. Biol. Chem. 271, 21422–21429 (1996)
  Article CAS Google Scholar
• Huang, P. et al. Functional role of a conserved motif in TM6 of the rat μ opioid receptor: constitutively active and inactive receptors result from substitutions of Thr6.34(279) with Lys and Asp. Biochemistry 40, 13501–13509 (2001)
  Article CAS Google Scholar
• Haga, K. et al. Structure of the human M2 muscarinic acetylcholine receptor bound to an antagonist. Nature 482, 547–551 (2012)
  Article ADS CAS Google Scholar
• Kruse, A. C. et al. Structure and dynamics of the M3 muscarinic acetylcholine receptor. Nature 482, 552–556 (2012)
  Article ADS CAS Google Scholar
• Disse, B. et al. Ba 679 BR, a novel long-acting anticholinergic bronchodilator. Life Sci. 52, 537–544 (1993)
  Article CAS Google Scholar
• Cassel, J. A., Daubert, J. D. & DeHaven, R. N. [3H]Alvimopan binding to the μ opioid receptor: comparative binding kinetics of opioid antagonists. Eur. J. Pharmacol. 520, 29–36 (2005)
  Article CAS Google Scholar
• Kurowski, M., Rosenbaum, J. S., Perry, D. C. & Sadee, W. [3H]-etorphine and [3H]-diprenorphine receptor binding in vitro and in vivo: differential effect of Na+ and guanylyl imidodiphosphate. Brain Res. 249, 345–352 (1982)
  Article CAS Google Scholar
• Sporer, K. A. Acute heroin overdose. Ann. Intern. Med. 130, 584–590 (1999)
  Article CAS Google Scholar
• Alford, B. T., Burkhart, R. L. & Johnson, W. P. Etorphine and diprenorphine as immobilizing and reversing agents in captive and free-ranging mammals. J. Am. Vet. Med. Assoc. 164, 702–705 (1974)
  CAS PubMed Google Scholar
• Wu, B. et al. Structures of the CXCR4 chemokine GPCR with small-molecule and cyclic peptide antagonists. Science 330, 1066–1071 (2010)
  Article ADS CAS Google Scholar
• Mansour, A. et al. Key residues defining the μ-opioid receptor binding pocket: a site-directed mutagenesis study. J. Neurochem. 68, 344–353 (1997)
  Article CAS Google Scholar
• Bonner, G., Meng, F. & Akil, H. Selectivity of μ-opioid receptor determined by interfacial residues near third extracellular loop. Eur. J. Pharmacol. 403, 37–44 (2000)
  Article CAS Google Scholar
• Zadina, J. E., Hackler, L., Ge, L. J. & Kastin, A. J. A potent and selective endogenous agonist for the μ-opiate receptor. Nature 386, 499–502 (1997)
  Article ADS CAS Google Scholar
• Seki, T. et al. DAMGO recognizes four residues in the third extracellular loop to discriminate between μ- and κ-opioid receptors. Eur. J. Pharmacol. 350, 301–310 (1998)
  Article CAS Google Scholar
• Rozenfeld, R., Gomes, I. & Devi, L. in The Opiate Receptors Vol. 23 (ed. Pasternak, G. W. ) Ch. 15 407–437 (Humana, 2011)
  Article Google Scholar
• Johnston, J. M. et al. Making structural sense of dimerization interfaces of δ opioid receptor homodimers. Biochemistry 50, 1682–1690 (2011)
  Article CAS Google Scholar
• Fanelli, F. & De Benedetti, P. G. Update 1 of: computational modeling approaches to structure-function analysis of G protein-coupled receptors. Chem. Rev. 111, PR438–PR535 (2011)
  Article CAS Google Scholar
• Hebert, T. E. et al. A peptide derived from a β2-adrenergic receptor transmembrane domain inhibits both receptor dimerization and activation. J. Biol. Chem. 271, 16384–16392 (1996)
  Article CAS Google Scholar
• Granier, S. et al. A cyclic peptide mimicking the third intracellular loop of the V2 vasopressin receptor inhibits signaling through its interaction with receptor dimer and G protein. J. Biol. Chem. 279, 50904–50914 (2004)
  Article CAS Google Scholar
• Hu, J. et al. Structural aspects of M3 muscarinic acetylcholine receptor dimer formation and activation. FASEB J. 26, 604–616 (2011)
  Article Google Scholar
• Park, J. H., Scheerer, P., Hofmann, K. P., Choe, H. W. & Ernst, O. P. Crystal structure of the ligand-free G-protein-coupled receptor opsin. Nature 454, 183–187 (2008)
  Article ADS CAS Google Scholar
• He, S. Q. et al. Facilitation of μ-opioid receptor activity by preventing δ-opioid receptor-mediated codegradation. Neuron 69, 120–131 (2011)
  Article CAS Google Scholar
• Jordan, B. A. & Devi, L. A. G-protein-coupled receptor heterodimerization modulates receptor function. Nature 399, 697–700 (1999)
  Article ADS CAS Google Scholar
• He, L., Fong, J., von Zastrow, M. & Whistler, J. L. Regulation of opioid receptor trafficking and morphine tolerance by receptor oligomerization. Cell 108, 271–282 (2002)
  Article CAS Google Scholar
• He, L. & Whistler, J. L. An opiate cocktail that reduces morphine tolerance and dependence. Curr. Biol. 15, 1028–1033 (2005)
  Article CAS Google Scholar
• George, S. R. et al. Oligomerization of μ- and δ-opioid receptors. Generation of novel functional properties. J. Biol. Chem. 275, 26128–26135 (2000)
  Article CAS Google Scholar
• Gomes, I., Ijzerman, A. P., Ye, K., Maillet, E. L. & Devi, L. A. G protein-coupled receptor heteromerization: a role in allosteric modulation of ligand binding. Mol. Pharmacol. 79, 1044–1052 (2011)
  Article CAS Google Scholar
• Vilardaga, J. P. et al. Conformational cross-talk between α2A-adrenergic and μ-opioid receptors controls cell signaling. Nature Chem. Biol. 4, 126–131 (2008)
  Article CAS Google Scholar
• Rasmussen, S. G. et al. Crystal structure of the β2 adrenergic receptor–Gs protein complex. Nature 477, 549–555 (2011)
  Article ADS CAS Google Scholar
• Fung, J. J. et al. Ligand-regulated oligomerization of β2-adrenoceptors in a model lipid bilayer. EMBO J. 28, 3315–3328 (2009)
  Article CAS Google Scholar
• Golebiewska, U., Johnston, J. M., Devi, L., Filizola, M. & Scarlata, S. Differential response to morphine of the oligomeric state of μ-opioid in the presence of δ-opioid receptors. Biochemistry 50, 2829–2837 (2011)
  Article CAS Google Scholar
• Portoghese, P. S., Sultana, M. & Takemori, A. E. Design of peptidomimetic δ opioid receptor antagonists using the message-address concept. J. Med. Chem. 33, 1714–1720 (1990)
  Article CAS Google Scholar
• Caffrey, M. & Cherezov, V. Crystallizing membrane proteins using lipidic mesophases. Nature Protocols 4, 706–731 (2009)
  Article CAS Google Scholar
• Otwinowski, Z. & Minor, W. Processing of X-ray diffraction data collected in oscillation mode. Methods Enzymol. 276, 307–326 (1997)
  Article CAS Google Scholar
• McCoy, A. J. et al. Phaser crystallographic software. J. Appl. Cryst. 40, 658–674 (2007)
  Article CAS Google Scholar
• Emsley, P. & Cowtan, K. Coot: model-building tools for molecular graphics. Acta Crystallogr. D 60, 2126–2132 (2004)
  Article Google Scholar
• Afonine, P. V., Grosse-Kunstleve, R. W. & Adams, P. D. A robust bulk-solvent correction and anisotropic scaling procedure. Acta Crystallogr. D 61, 850–855 (2005)
  Article Google Scholar
• Chen, V. B. et al. MolProbity: all-atom structure validation for macromolecular crystallography. Acta Crystallogr. D 66, 12–21 (2010)
  Article CAS Google Scholar
• Schrodinger, L. The PyMOL Molecular Graphics System v.1.3r1. (2010)